MWNA
WMGI

Marshall Wace North America’s Wright Medical Group Inc WMGI Stock Holding History

Marshall Wace North America’s Portfolio WMGI Stock Details WMGI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-57,515
Closed -$1.76M – 1720
2020
Q3 		$1.76M Buy
+57,515
New +$1.74M 0.01% 630
2020
Q1 		– Sell
-850
Closed -$26K – 1746
2019
Q4 		$26K Sell
850
-43,858
-98% -$1.15M ﹤0.01% 1193
2019
Q3 		$922K Buy
44,708
+1,365
+3% +$32.5K 0.01% 710
2019
Q2 		$1.29M Buy
+43,343
New +$1.32M 0.01% 678
2019
Q1 		– Sell
-23,709
Closed -$645K – 2053
2018
Q4 		$645K Sell
23,709
-25,089
-51% -$693K 0.01% 717
2018
Q3 		$1.42M Sell
48,798
-260,509
-84% -$7.02M 0.01% 551
2018
Q2 		$8.03M Buy
+309,307
New +$7.07M 0.05% 387
2017
Q4 		– Sell
-105,457
Closed -$2.74M – 1715
2017
Q3 		$2.74M Sell
105,457
-278,756
-73% -$7.68M 0.02% 711
2017
Q2 		$10.4M Buy
+384,213
New +$10.9M 0.08% 306

Other funds holding WMGI

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Marshall Wace North America's WMGI Position: Q4 2020 in Review

Marshall Wace North America sold out of Wright Medical Group Inc (WMGI) in Q4 2020, closing a stake of 57,515 shares — an estimated $1.76M sold.

Marshall Wace North America first reported a position in WMGI in Q2 2017 and held it in 9 quarters. The position peaked at $10.4M in Q2 2017. 1 fund tracked by Wall St. Rank holds WMGI as of Q4 2020.

  • Marshall Wace North America reported no remaining Wright Medical Group Inc position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 57,515 Wright Medical Group Inc shares in Q4 2020, an estimated $1.76M.
  • Marshall Wace North America first reported a position in Wright Medical Group Inc in Q2 2017 and held it in 9 quarters.
  • Marshall Wace North America's Wright Medical Group Inc position peaked at $10.4M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Wright Medical Group Inc as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.